Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Hypocretin-1 and -2 (Hcrt-1 and Hcrt-2), also referred to as orexin-A and -B, are neuropeptides synthesized by a few thousand neurons in the lateral hypothalamus. Hypocretin-containing neurons project throughout the brain, with a prominent input to basal forebrain structures involved in motivation, reward, and stress. However, the role of hypocretins in addiction-related behaviors remains largely unexplored. Here we show that intracerebroventricular infusions of Hcrt-1 lead to a dose-related reinstatement of cocaine seeking without altering cocaine intake in rats. Hcrt-1 also dramatically elevates intracranial self-stimulation thresholds, indicating that, unlike treatments with reinforcing properties such as cocaine, Hcrt-1 negatively regulates the activity of brain reward circuitries. Hypocretin-induced reinstatement of cocaine seeking was prevented by blockade of noradrenergic and corticotropin-releasing factor systems, suggesting that Hcrt-1 reinstated drug seeking through induction of a stress-like state. Consistent with this interpretation, the selective Hcrt-1 receptor antagonist SB-334867 blocked footshock-induced reinstatement of previously extinguished cocaine-seeking behavior. These findings reveal a previously unidentified role for hypocretins in driving drug seeking through activation of stress pathways in the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additional studies demonstrate that intraventricular Hcrt-1 elevates intracranial self-stimulation thresholds, suggesting an aversive effect of excessive activation of the Hcrt system (Boutrel et al., 2005).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Boutrel et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
A stereotaxic atlas of the rat brain
Pellegrino, L. J., & Cushman, A. J. (1967) · Plenum Press eBooks · Cited by 4,688
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., et al. (2000) · Nature Medicine · doi:10.1038/79690 · Cited by 2,118
Reduced Number of Hypocretin Neurons in Human Narcolepsy
Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., & Siegel, J. M. (2000) · Neuron · doi:10.1016/s0896-6273(00)00058-1 · Cited by 2,089
Shaffer, J. P. (1995) · Annual Review of Psychology · doi:10.1146/annurev.ps.46.020195.003021 · Cited by 1,960
Research works printed but not linked: 5
- 10.1097/00075197-200307000-00001 · doi:10.1097/00075197-200307000-00001
- Boutrel, B., Kenny, P. J., Markou, A. & Koob, G. F. (2005) in Hypocretins: Integrators of Physiological Functions, eds. de Lecea, L. & Sutcliffe, J. G. (Springer, New York), pp. 315-324.
- Kornetsky, C. & Esposito, R. U. (1979) Fed. Proc. 38**,** 2473-2476. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/488370/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Fed.%20Proc.&volume=38&publication_year=1979&pages=2473&pmid=488370&)]
- 10.1037/1064-1297.6.3.255 · doi:10.1037/1064-1297.6.3.255
- Horvath, T. L., Peyron, C., Diano, S., Ivanov, A., Aston-Jones, G., Kilduff, T. S. & van den Pol, A. N. (1999) J. Comp. Neurol. 415**,** 145-159. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10545156/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J.%20Comp.%20Neurol.&volume=415&publication_year=1999&pages=145&pmid=10545156&)] · doi:10.1002/(sici)1096-9861(19991213)415:2<145::aid-cne1>3.0.co;2-2
Cited by
Items 401–500 of 526
Translational Approaches to Medication Development
Bartlett, S. E., & Heilig, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-28720-6_132 · Cited by 8
Steady-state methadone effect on generalized arousal in male and female mice.
Devidze, N., Zhou, Y., Ho, A., Zhang, Q., Pfaff, D. W., & Kreek, M. J. (2008) · Behavioral Neuroscience · doi:10.1037/a0013276 · Cited by 7
The Human Orexin/Hypocretin Receptor Crystal Structures
Yin, J., & Rosenbaum, D. M. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_52 · Cited by 7
Why do people overeat? Hunger, psychological eating and type 2 diabetes
Wheatley, S. D., & Whitaker, M. J. (2019) · Practical Diabetes · doi:10.1002/pdi.2232 · Cited by 8
Simmons, S. J., Gentile, T. A., Mo, L., Tran, F. H., Ma, S., & Muschamp, J. W. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.053 · Cited by 9
Role of Lateral Hypothalamic Orexin (Hypocretin) Neurons in Alcohol Use and Abuse: Recent Advances
Walker, L. C., Ch’ng, S. S., & Lawrence, A. J. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0069-7 · Cited by 7
“These findings were expanded to voluntary drug self-administration, whereby central infusions of OX increased reinstatement of cocaine seeking in rats [17], while Lawrence et al.”
BackgroundBeckenstrom, A. C., Coloma, P. M., Dawson, G. R., Finlayson, A., Malik, A., Post, A., Steiner, M. A., & Potenza, M. N. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105107 · Cited by 8
Probiotics in Neurology and Psychiatry
Forsythe, P., & Bienestock, J. (2014) · ASM Press eBooks · doi:10.1128/9781555815462.ch22 · Cited by 7
The roles of orexins on sleep/wakefulness, energy homeostasis and intestinal secretion
Mäkelä, K. A. (2010) · Cited by 7
The Orexin System in Addiction: Neuromodulatory Interactions and Therapeutic Potential
Capó, T., Lillo, J., Rebassa, J. B., Badia, P., Raïch, I., Cubeles-Juberias, E., Reyes‐Resina, I., & Navarro, G. (2025) · Brain Sciences · doi:10.3390/brainsci15101105 · Cited by 7
“Central administration of OXA induces a dose-dependent reinstatement of cocaine-seeking behavior, an effect that can be blocked by CRF receptor (CRFR) and OX 1 R antagonists [138].”
Hoyer, D., & Jacobson, L. H. (2024) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2024.100190 · Cited by 7
Interaction between sleep mechanisms and orexin neurons
Junko, H. A. R. A., & Sakurai, T. (2011) · Sleep and Biological Rhythms · doi:10.1111/j.1479-8425.2010.00466.x · Cited by 6
Orexin receptors in GtoPdb v.2021.3
Coleman, P. J., de Lecea, L., Gotter, A. L., Hagan, J. J., Hoyer, D., Kilduff, T. S., Kukkonen, J. P., Porter, R. A., Renger, J. J., Siegel, J. M., et al. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f51/2021.3 · Cited by 6
Effects of inhibiting the orexin system on nicotine reward memory and fear memory
Cui, P., Wu, D., Dong, J., Chen, Y. F., Feng, J., Liu, X., Chen, Z., Ge, J., & Liu, J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110523 · Cited by 5
Clark, P. J., Migovich, V. M., Das, S., Xu, W., Zhang, Y., Kortagere, S., & España, R. A. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-025-02315-9 · Cited by 5
“For example, hypocretin-1 peptide increases motivation for cocaine [19] and reinstates cocaine-seeking [20, 21], while hypocretin receptor 1 (Hcrtr1) antagonism decreases motivation for cocaine [22 – 28] and blocks reinstatement of cocaine-seeking [29 – 31].”
Neurobiology of negative reinforcement as a driving force in alcohol addiction
Vendruscolo, L. F., & Koob, G. F. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.038 · Cited by 5
Self-citationMun, C. J., Reid, M. J., Sarandos, S., Elam, K. K., Celine Mylx, L. I., & Strickland, J. C. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00598-4 · Cited by 5
“More broadly, orexin regulation and the modulation of complex behaviors like substance use involve extrahypo-thalamic projections to the limbic system, locus coeruleus, and ventral tegmental area (VTA) [63, 64].”
Exploring Addictive Online Behaviors in Patients with Narcolepsy Type 1
Varallo, G., Musetti, A., D’Anselmo, A., Gori, A., Giusti, E. M., Pizza, F., Castelnuovo, G., Plazzi, G., & Franceschini, C. (2022) · Healthcare · doi:10.3390/healthcare10112169 · Cited by 6
Gaulden, A. D., Tepe, E. A., Sia, E., Rollins, S. S., & McReynolds, J. R. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.114840 · Cited by 5
“Studies using preclinical models of stress-cocaine interactions mostly examine the context of either acquisition of cocaine self-administration (SA; [14,15,16]) or reinstatement of cocaine-seeking behavior [17,18, 19,20].”
A New Peptide Input to Learning and Addiction
Wise, R. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.028 · Cited by 5
“Intraventricular (Boutrel et al., 2005) or VTA (Harris et al., 2005) infusions of orexin are known to reinstate drug-seeking in rodents, as do intraventricular (Shaham et al., 1997) or VTA (Wang et al., 2005) infusions of CRF. Ventral tegmental injections of an orexin antagonist block the…”
BackgroundBoutrel, B. (2006) · médecine/sciences · doi:10.1051/medsci/20062267573 · Cited by 5
“Telle a été notre approche pour l’étude de l’implication du système Hcrt dans les mécanismes neurobiologiques responsables de la vulnérabilité au risque de rechute [13].”
Self-citationMazaheri, S., Zendehdel, M., & Haghparast, A. (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102353 · Cited by 4
Schmeichel, B. E., & Berridge, C. W. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000734 · Cited by 4
“For example, central HCRT administration reinstates previously extinguished drug-seeking (Boutrel et al., 2005; Harris et al., 2005), while treatment with an HCRT-R1 antagonist prevents stressor-induced reinstatement of cocaine-induced drug-seeking (Boutrel et al., 2005).”
InfluentialKoob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816990-2.00001-6 · Cited by 4
Self-citationOrexina: implicaciones clínicas y terapéuticas
Mediavilla, C., & Risco, S. (2014) · Revista de Neurología · doi:10.33588/rn.5803.2013349 · Cited by 7
Chen, K.-T., Huang, M., Lin, C., Chang, H., & Kao, C.-F. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2023.2297661 · Cited by 4
“Blockade of HCRTR1 not only abolished reinstatement of alcohol and cocaine-seeking behavior but also reduced nicotine self-administration (18–20).”
BackgroundMitchell, C. S., Mohammadkhani, A., Manning, E. E., Campbell, E. J., Fisher, S. D., Yeoh, J. W., Pearl, A. J., Burton, N. J., Qiao, M., Iredale, J. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.05.979468 · Cited by 4
Do orexin/hypocretin neurons track sensory, cognitive, or motor information?Preprint
Bracey, E. F., Aravind, A., Grujic, N., Peleg‐Raibstein, D., & Burdakov, D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.13.488195 · Cited by 4
Sarfi, M., Salmani, M. E., Lashkarbolouki, T., & Goudarzi, I. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.173997 · Cited by 3
Berry, E. A., Huhulea, E. N., Ishibashi, M., McGregor, R., Siegel, J. M., & Leonard, C. S. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-25.2025 · Cited by 4
Dopaminergic Transmission and Wake-Promoting Effects of Central Nervous System Stimulants
Brown, R. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-46437-4_2 · Cited by 5
“Orexin/hypocretin activation of VTA dopamine neurons has been implicated in reinstatement of drug seeking behavior (Boutrel et al. 2005).”
BackgroundHypocretin Receptor 1 Regulation of Dopamine Neurotransmission and Motivated Behavior
Shaw, J. K., Black, E. M., Zhang, Y., & España, R. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813751-2.00005-x · Cited by 3
Richardson, K. A., Sweatt, N., Tran, H., Apprey, V., Uthayathas, S., Taylor, R. E., & Gupta, K. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00005 · Cited by 3
“This observation has also been reported in the literature for orexin neurons after a myriad of behavioral and pharmacological studies, including those to measure the c-Fos, activation of orexin neurons after behavioral testing for reward, reinstatement, feeding, stress and arousal (Boutrel et al., 2005; Harris et al.,…”
BackgroundOrexin receptors in GtoPdb v.2023.1
Aston‐Jones, G., Bonaventure, P., Coleman, P. J., de Lecea, L., Hartman, D., Hoyer, D., Jacobson, L. H., Kilduff, T. S., Kukkonen, J. P., McDonald, T. P., et al. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f51/2023.1 · Cited by 3
O’Byrne, J., Salimi, A., & Dang‐Vu, T. T. (2016) · Springer eBooks · doi:10.1007/978-3-319-23739-8_13 · Cited by 3
Hoyer, D., & Jacobson, L. H. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0099-7 · Cited by 3
(2012) · Progress in brain research · doi:10.1016/c2011-0-06162-8 · Cited by 3
Murray, C. M., Fox, J. C., Heidbreder, C. A., & Young, M. A. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.104053 · Cited by 2
“SB-334867 also blocked stress-induced reinstatement of extin-guished cocaine-seeking behaviour (Boutrel et al., 2005; Zhou et al., 2012) and reversed conditioned reinstatement that was induced by cocaine-associated stimuli (Martin-Fardon and Weiss, 2014; Smith et al., 2009; Zhou et al., 2012).”
Orexin Receptor Functions in the Ascending Arousal System
Leonard, C. S., & Ishibashi, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-23078-8_5 · Cited by 2
The anxiogenic drug yohimbine is a reinforcer in male and female rats
Renda, B., & Leri, F. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01985-1 · Cited by 4
Jana, S., Ahmadi, P., Yan, X., Bai, P., Liow, J., Jenson, A. E., Pamie-George, M. T., Zoghbi, S. S., Wu, S., Wang, C., et al. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00382b · Cited by 2
Glutamatergic Modulation of Cue-Induced Drug-Seeking Behavior in the Rat
Bäckström, P. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 2
Sakurai, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-23078-8_1 · Cited by 3
Recent Chronology of Orexin Pharmacology and Its Potential as a Treatment for Primary Insomnia
Winrow, C. J., Gotter, A. L., Coleman, P. J., Hargreaves, R. J., & Renger, J. J. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00416 · Cited by 2
Hypocretin (Orexin) in Models of Cocaine Addiction
Gentile, T. A., Simmons, S. J., & Muschamp, J. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803750-8.00024-5 · Cited by 2
Pharmacology of Orexin/Hypocretin Receptors
Kukkonen, J. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813751-2.00002-4 · Cited by 2
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-816988-9.00001-1 · Cited by 2
Self-citationStannous fluoride: does it stain teeth? How does it react with tooth surfaces? A review.
Shannon, I. L. (1978) · PubMed · Cited by 2
Hypocretin signaling in the central amygdala drives methamphetamine self-administration in male rats
Zarin, T. A., Brandner, A. J., Zhang, Y., Koob, G. F., & Schmeichel, B. E. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110653 · Cited by 1
Self-citationFlores‐Ramirez, F. J., & Martin‐Fardon, R. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110895 · Cited by 1
“…increases anxiety-like behavior and reinstates drug seeking in a CRF-dependent manner, indicated by elevations of intracranial self-stimulation thresholds and an increase in cocaine-seeking behavior in preclinical animal models (Boutrel et al., 2005; Hata et al., 2011; Suzuki et al., 2005).”
Self-citationHypothalamic regulation of energy homeostasis: Quo vadis
López, M., & Friedman, J. M. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10042-9 · Cited by 2
“…Cowley [164, 165], Lora K. Heisler [166–169], Takeshi Saku-rai and Masashi Yanagisawa [170–176], Luis de Lecea and J. Gregor Sutcliffe [ 172, 177–179], Kamal Rahmouni [180– 185], Miguel López and Antonio Vidal-Puig [186], Jens Mit-tag and Björn Vennström [187–189], Sebastian G. Bouret and…”
Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice
Sharma, A., 瀬川英美子, Chen, X., Park, S., Wang, S., Irmen, R. E., Constantino, N. J., Wang, C., Kanan, M. F., Colonna, M., et al. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00948-y · Cited by 1
“Beyond their roles in feeding and energy homeostasis [14], orexins modulate reward-seeking [67], addiction [68], and sleep–wake regulation [13, 69].”
Factors regulating stress-induced alcohol-seeking and pharmacotherapeutic treatments
Lawrence, A. J. (2009) · Alcohol · doi:10.1016/j.alcohol.2009.08.006 · Cited by 1
Stimulant Reversal of Cognitive Deficits
Wesensten, N. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511783005.007 · Cited by 1
Stress, Anxiety, and Cocaine Abuse
Craige, C. P., Enman, N. M., & Unterwald, E. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00006-x · Cited by 2
Addictive Drugs and Synaptic Plasticity
Vicente, J., Flores, G., Sihra, T. S., & Rodriguez-Moreno, A. (2012) · InTech eBooks · doi:10.5772/33299 · Cited by 1
Animal studies trigger new insights on the use of methadone maintenance
Cummins, E., & Leri, F. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902915533 · Cited by 2
Drug Discovery and Development for Reward Disorders: Views from Government
McCann, D. J., Acri, J. B., & Vocci, F. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00022-9 · Cited by 1
Masoudi, S. (2015) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000280 · Cited by 2
“Thus, hypocretin neurons influence multiple brain areas and are involved in the coordination of feeding, emotions, reward, arousal, drug addiction and energy homeostasis [97-100].”
BackgroundOrexin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Coleman, P. J., de Lecea, L., Gotter, A. L., Hagan, J. J., Hills, R., Kilduff, T. S., Kukkonen, J. P., Porter, R. A., Renger, J. J., Siegel, J. M., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f51/2019.4 · Cited by 2
Flores‐Ramirez, F. J., Illenberger, J. M., & Martin‐Fardon, R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100695 · Cited by 1
“The same study (Boutrel et al., 2005) also found that inhibiting noradrenergic and CRF systems prevented drug-seeking behavior that was induced by OX, which may imply that OXA may trigger drug-seeking behavior by inducing a “ stress-like ” state via these systems.”
InfluentialSelf-citationPharmacotherapy of Cocaine Addiction
Elkashef, A. M., & Vocci, F. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_50 · Cited by 2
The Role of Ghrelin in Reward-Based Feeding
St-Onge, V. (2014) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2014-10569 · Cited by 1
Mitchell, C. S., Mohammadkhani, A., Manning, E. E., Campbell, E. J., Fisher, S. D., Yeoh, J. W., Pearl, A. J., Burton, N. J., Qiao, M., Iredale, J. A., et al. (2024) · eLife · doi:10.7554/elife.97707 · Cited by 1
Narcolepsie chez l'enfant : caractéristiques cliniques et approches thérapeutiques
Inocente, C. O. (2015) · theses.fr (ABES) · doi:10.70675/171a0cfez76bfz4c40za073z948e205f4871 · Cited by 1
Mapping the Neural Mechanisms by which Leptin Regulates Distinct Physiological Functions.
Louis, G. W. (2010) · Deep Blue (University of Michigan)
Phospholipase Cascades in OX1 Orexin Receptor Signaling
Jäntti, M. H. (2014) · Helda - University of Helsinki Institutional Repository
The Hypocretins/Orexins: Master Regulators of Arousal and Hyperarousal
Carter, M. E., Adamantidis, A., & de Lecea, L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8390-9_11
“Hcrt neurons project to the VTA, a critical site of synaptic plasticity induced by addictive drugs [8, 9]. Stimulation of Hcrt neurons or microinjection of Hcrt1 into the VTA or ventricles reinstates previously extinguished drug-seeking behaviors, and these effects are blocked by a Hcrtr1 antagonist [8, 9 ]. In vitro…”
BackgroundOrexin Neural Activity Associated with Morphine Spontaneous Withdrawal-Induced Anxiety in Rats
Ly, R. (2011) · Digital Commons @ Connecticut College (Connecticut College)
Smoking and Mental Health Problems
Caillé, S., Baker, A., Todd, J., Turner, A., & Dayas, C. V. (2015) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000369483
Hypocretin (Orexin), Dopamine, and Goal-Directed Behavior
Muschamp, J. W. (2007)
Orexin/Hypocretin, Drug Addiction, and Narcolepsy
Dileone, R., Sarhan, M., & Sharf, R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8390-9_23
“In contrast, intracerebroventricular (icv) administration of orexin A [37] or treatment with SB-334867 [38] fails to affect responding during active cocaine selfadministration.”
BackgroundInfluentialHypocretin receptor antagonists for insomnia: rationale and clinical data
Ruoff, C. M., & Guilleminault, C. (2012) · Clinical Investigation · doi:10.4155/cli.12.49
Wei, C., Li, Y., Han, J., Wang, H., & Sui, N. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2010.00047
Goudarzi, E., Salmani, M. E., bluki, T. L., & Goudarzi, I. (2014) · مجله دانشگاه علوم پزشکی اراک
Borgland, S. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8390-9_22
“The ox/hcrt-R1 antagonist, SB 334867, attenuates high-fat food pellet [68], ethanol [49, 66], and nicotine [51] self-administration, but not selfadministration of cocaine [ 46 , 67], water [49], or food [46].”
BackgroundInfluentialLutter, M. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8390-9_25
“Finally, in a study looking at the role of orexin signaling in the reinstatement of cocaine seeking behaviors, Boutrel and colleagues reported that icv administration of orexin-A increased the intracranial self stimulation (ICSS) threshold [30].”
BackgroundCues Linked to the Consumption of Chocolate: Orexin and Reward-Based Feeding Behaviors
Choi, D. L., Davis, J. F., & Benoit, S. C. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-803-0_35
“Similar results have been demonstrated with other substances of abuse using OX1R blockade to attenuate operant responding for alcohol and the reinstatement of alcohol and cocaine seeking [ 47, 48 ] .”
ResultHumor Processing in Human Narcolepsy with Cataplexy
Ponz, A., & Schwartz, S. (2008) · Springer eBooks · doi:10.1007/978-1-4419-0854-4_11
Dileone, R., Narayanan, N. S., & Guarnieri, D. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3492-4_4
“In contrast, intracerebroventricular (ICV) administration of orexin A [ 107 ] or treatment with SB-334867 [ 108 ] fails to affect responding during cocaine self-administration.”
BackgroundInfluentialA review of research and articles published on Orexin in the last decade
Zarmehri, H. A., & allahdadi, M. (2014) · Journal of Torbat Heydariyeh University of Medical Sciences
de Oliveira, W. F. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2015.tde-07122015-152245
Novel pathways for stimulant development II: the hypocretin/orexin system
Pasumarthi, R. K., & Kilduff, T. S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511783005.014
Orexin/Hypocretin System and Drug Addiction
Matzeu, A., & Martin‐Fardon, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00015-9
Self-citationInvestigating the physiological role of hypothalamic glucokinase in appetite and glucose homeostasis
Hussain, S. S. (2013) · Spiral (Imperial College London) · doi:10.25560/14696
Contribution of Opioid and Stress Systems to Impulsive Action in Rodent Models
Mahoney, M. K. (2015) · QSpace (Queen's University Library)
Optogenetic Probing of Hypocretins’ Regulation of Wakefulness
Adamantidis, A., & de Lecea, L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8390-9_12 · Cited by 1
“Regarding the implication of the Hcrt system in brain reward and stress [55, 56 ], it is possible that activation of Hcrt neurons facilitates hyperarousal (defined as a transient “hyper-alertness” state triggered by salient stress or reward) when an animal is actively engaged in goal-oriented behaviors such as food- o…”
BackgroundAgostinho, B. V. F. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2016.tde-09112016-093236
Dayot, S. (2018) · theses.fr (ABES) · doi:10.70675/ab640e17z2bb2z4b45za125z628f3fd7c50f
“…des récepteurs de la corticotropine (CRH) ou d’un agoniste des récepteurs α2 clonidine a, respectivement, réduit et bloqué cet effet, suggérant que le rôle de l’orexine dans le comportement de recherche de récompense est médié par la CRH et les systèmes noradrénergiques (Boutrel et al., 2005).”
Matzeu, A., & Martin‐Fardon, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813751-2.00006-1
Self-citationThe regulation of orexin receptor function by dynein light chains
Bélanger-Nelson, E. (2011) · eScholarship@McGill (McGill) · doi:10.82308/12051
Banerjee, A., Sengupta, T., & Mallick, H. N. (2020) · Sleep and Vigilance · doi:10.1007/s41782-020-00103-7
Emotional Processing in Narcolepsy
Schwartz, S. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8390-9_24
“As suggested by recent animal work [22, 23 , 28, 30], Hcrt depletion may affect dopaminergic modulation within brain reward networks, which would also be consistent with the observation that the midbrain/VTA remained unresponsive to highly motivating cues in NC patients.”
ResultGentile, T. A. (2018) · TUScholarShare (Temple University)
Sebastiano, D., & Andrea, R. C. (2012) · Scholarship@Western (Western University)
Adamantidis, A., & de Lecea, L. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_2300
de Lecea, L. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_305
de Lecea, L. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_305-3
de Lecea, L. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_305
Metadata
- Authors
- Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., & de Lecea, L.
- Affiliations
- Scripps Research Institute (US)
- Center for Psychiatric Neuroscience and Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent (SUPEA), Centre Hospitalier Universitaire Vaudois-Département de Psychiatrie (CHUV-DP), University of Lausanne, CH-1008 Prilly, Switzerland; and Departments of Molecular Biology and Molecular and Integrative Neurosciences, The Scripps Research Institute, La Jolla, CA 92037
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-12-15
- Volume
- 102
- Issue
- 52
- Pages
- 19168-19173
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1323172
- OpenAlex
- W2098772655
- Cited by
- 520
- References
- 48
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 18 · 2023: 15 · 2022: 15 · 2021: 13 · 2020: 16 · 2019: 13 · 2018: 30 · 2017: 17 · 2016: 27 · 2015: 29 · 2014: 38 · 2013: 33 · 2012: 47
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (1r21aa013241-01)
- National Institute on Alcohol Abuse and Alcoholism (AA13241)
- National Institute of Mental Health (R01MH058543, MH 58543)
- National Institute on Drug Abuse (DA07348, R01DA007348, DA04398, DA 11946, R37DA007348, R56DA011946, R01DA004398, R01DA011946)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- orexin-A, orexin, cocaine seeking, reinstatement of drug seeking, stress, noradrenergic system, corticotropin-releasing factor, intracranial self-stimulation, reward systems, addiction, footshock, SB-334867, lateral hypothalamus
- MeSH terms
- Orexins, Analysis of Variance, Animals, Benzoxazoles, Brain, Cocaine, Dose-Response Relationship, Drug, Male, Naphthyridines, Neuropeptides, Reward, Self Administration, Time Factors, Urea, Models, Statistical, Behavior, Addictive, Rats, Wistar, Cocaine-Related Disorders, Intracellular Signaling Peptides and Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.